Atlas Trials

Panobinostat Plus Ifosfamide, Carboplatin, and Etoposide (ICE) Compared With ICE For Relapsed Hodgkin Lymphoma

Clinical trial NCT01169636 · COMPLETED

Trial details

NCT number
NCT01169636
Sponsor
M.D. Anderson Cancer Center
Status
COMPLETED
Phase
Phase 1, Phase 2
Study type
INTERVENTIONAL
Hodgkin's Lymphoma
Start date
2011-01-31
Primary completion
2017-05-17
Enrollment
62

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.